0000899243-22-030439.txt : 20220906
0000899243-22-030439.hdr.sgml : 20220906
20220906170835
ACCESSION NUMBER: 0000899243-22-030439
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220901
FILED AS OF DATE: 20220906
DATE AS OF CHANGE: 20220906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dion Gisele
CENTRAL INDEX KEY: 0001873088
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39676
FILM NUMBER: 221229003
MAIL ADDRESS:
STREET 1: C/O CYTEK BIOSCIENCES, INC.
STREET 2: 46107 LANDING PARKWAY
CITY: FREMONT
STATE: CA
ZIP: 94538
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inhibikase Therapeutics, Inc.
CENTRAL INDEX KEY: 0001750149
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900
CITY: ATLANTA
STATE: GA
ZIP: 30339
BUSINESS PHONE: 678-392-3419
MAIL ADDRESS:
STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900
CITY: ATLANTA
STATE: GA
ZIP: 30339
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-09-01
0
0001750149
Inhibikase Therapeutics, Inc.
IKT
0001873088
Dion Gisele
C/O INHIBIKASE THERAPEUTICS, INC.
3350 RIVERWOOD PARKWAY SE, SUITE 1900
ATLANTA
GA
30339
1
0
0
0
Stock Option (right to buy)
0.95
2022-09-01
4
A
0
60000
0.00
A
2032-09-01
Common Stock
60000
60000
D
The option shares vest 50% on each of the first two anniversaries of September 1, 2022.
/s/ Milton H. Werner, Attorney-In-Fact
2022-09-06